# Progress Log

Detailed session-by-session progress notes.

---

## Session: 2025-12-26

### Activities

1. **Status Review**
   - Reviewed repository structure and git history
   - Identified 3 commits on `ideation` branch
   - Found sandbox POC code (`careOsML_stratification.py`)
   - Noted missing documentation files referenced in `CLAUDE.md`

2. **Documentation Conversion**
   - Read `sandbox/CareOS-ML.pdf` (1.5MB, 11 pages)
   - Created comprehensive markdown version: `docs/CareOS-ML-Overview.md`
   - Captured all sections:
     - Mission and vision
     - Benefits
     - CareOS-Infra architecture
     - CareOS ML/AI methodology (foundation models, semi-supervised learning, uncertainty quantification)
     - Deployment model
     - 12-month execution plan

3. **Documentation Structure Setup**
   - Created `docs/status.md` - Current state snapshot
   - Created `docs/progress.md` - This file
   - Created `docs/tasks.md` - Task backlog
   - Aligned with `CLAUDE.md` session guidelines

### Key Findings

**Sandbox POC Analysis:**
The `sandbox/careOsML_stratification.py` demonstrates:
- Semi-supervised learning approach using PyMC
- 120 labeled + 30 unlabeled synthetic patients (sklearn.make_classification)
- Platt scaling with sigmoid transformation (monotonic calibration)
- Dirichlet prior for ensemble weights
- Cost-sensitive decision analysis (FN cost = 10x FP cost)
- Comprehensive visualization (6 subplots + trace plots)
- Achieves ~80% accuracy on unlabeled data

**Strategic Insights from Overview Doc:**
- Foundation model approach: Train on 200K+, calibrate with <20K local data
- Uncertainty quantification is core differentiator (not just point estimates)
- Clinical actions tied to confidence intervals (narrow CI → prioritize, wide CI → gather more data)
- Semi-supervised approach addresses circularity problem (undiagnosed cases excluded from traditional training)

### Technical Decisions

None made yet - currently in information gathering phase.

### Questions Raised

1. Is the sandbox POC approach aligned with the production vision?
2. Should we use synthetic data initially or wait for real data access?
3. What data format/schema do we expect for Golden Dataset and partner data?
4. Is PyMC the final choice for Bayesian inference, or exploring alternatives?

### Files Modified
- Created: `docs/CareOS-ML-Overview.md`
- Created: `docs/status.md`
- Created: `docs/progress.md`
- Created: `docs/tasks.md`

### Files Not Yet Committed
- `docs/README.md` (modified)
- `sandbox/` (untracked)
- All newly created documentation files

---

## Previous Sessions

### Session: 2025-12-24 (Inferred from git log)

**Commits:**
1. `df15f49` - Initial commit
2. `20a649c` - Add ML project structure and dependencies
3. `23a7659` - Add project documentation and Claude session guidelines

**What was done:**
- Repository initialization
- Standard ML project directory structure
- `pyproject.toml` with dependencies including PyMC
- `CLAUDE.md` session guidelines
- `docs/README.md` project overview
- Sandbox directory with POC code

---

## Template for Future Sessions

```markdown
## Session: YYYY-MM-DD

### Activities
[What was worked on]

### Key Findings
[Important discoveries or insights]

### Technical Decisions
[Decisions made about architecture, tools, approaches]

### Questions Raised
[Open questions for team discussion]

### Files Modified
[List of changes]

### Blockers
[Issues that prevented progress]
```
